Cargando…

Antimicrobial efficacy of 0.8% Hyaluronic Acid and 0.2% Chlorhexidine against Porphyromonas gingivalis strains: An in-vitro study

OBJECTIVE: The aim of the present in-vitro study was to assess antimicrobial efficacy of 0.8% hyaluronic acid (HA) and 0.2% Chlorhexidine gluconate (CHX) against Porphyromonas gingivalis (P. gingivalis). METHODS: The study was performed between December 2018 and March 2019 at the College of Dentistr...

Descripción completa

Detalles Bibliográficos
Autores principales: Binshabaib, Munerah, Aabed, Kawther, Alotaibi, Fitoon, Alwaqid, Milaf, Alfraidy, Aljohara, Alharthi, Shatha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994868/
https://www.ncbi.nlm.nih.gov/pubmed/32063942
http://dx.doi.org/10.12669/pjms.36.2.1456
_version_ 1783493271999217664
author Binshabaib, Munerah
Aabed, Kawther
Alotaibi, Fitoon
Alwaqid, Milaf
Alfraidy, Aljohara
Alharthi, Shatha
author_facet Binshabaib, Munerah
Aabed, Kawther
Alotaibi, Fitoon
Alwaqid, Milaf
Alfraidy, Aljohara
Alharthi, Shatha
author_sort Binshabaib, Munerah
collection PubMed
description OBJECTIVE: The aim of the present in-vitro study was to assess antimicrobial efficacy of 0.8% hyaluronic acid (HA) and 0.2% Chlorhexidine gluconate (CHX) against Porphyromonas gingivalis (P. gingivalis). METHODS: The study was performed between December 2018 and March 2019 at the College of Dentistry at the Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia. The P. gingivalis biofilms were formed and grown for 72 hours at 37°C under anaerobic conditions on glass slides coated with human saliva. The slides were individually positioned and exposed to 0.8% HA or 0.2% CHX. Therapeutically, the biofilms were divided into 3 groups as follows: (a) negative group; (b) 0.8% HA group and (c) 0.2% CHX group. P-values less than 0.05 were considered statistically significant. RESULTS: In the 0.8% HA group, P. gingivalis CFUs/ml were significantly higher at baseline than at 24- (P<0.05), 48 (P<0.05) and 72 hours (P<0.05) intervals. In the 0.2% CHX group, P. gingivalis CFUs/ml were significantly higher at baseline than at 72 hours interval (P<0.05). In the CHX group, there was no difference in P. gingivalis CFUs/ml between baseline, 24- and 48-hours intervals. At 48- and 72-hours intervals, the P. gingivalis CFUs/ml were significantly higher in the 0.2% CHX group compared with the 0.8% HA group. CONCLUSION: In-vitro, 0.8% HA is more effective in reducing the P. gingivalis CFUs/ml compared with 0.2% CHX.
format Online
Article
Text
id pubmed-6994868
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Professional Medical Publications
record_format MEDLINE/PubMed
spelling pubmed-69948682020-02-14 Antimicrobial efficacy of 0.8% Hyaluronic Acid and 0.2% Chlorhexidine against Porphyromonas gingivalis strains: An in-vitro study Binshabaib, Munerah Aabed, Kawther Alotaibi, Fitoon Alwaqid, Milaf Alfraidy, Aljohara Alharthi, Shatha Pak J Med Sci Original Article OBJECTIVE: The aim of the present in-vitro study was to assess antimicrobial efficacy of 0.8% hyaluronic acid (HA) and 0.2% Chlorhexidine gluconate (CHX) against Porphyromonas gingivalis (P. gingivalis). METHODS: The study was performed between December 2018 and March 2019 at the College of Dentistry at the Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia. The P. gingivalis biofilms were formed and grown for 72 hours at 37°C under anaerobic conditions on glass slides coated with human saliva. The slides were individually positioned and exposed to 0.8% HA or 0.2% CHX. Therapeutically, the biofilms were divided into 3 groups as follows: (a) negative group; (b) 0.8% HA group and (c) 0.2% CHX group. P-values less than 0.05 were considered statistically significant. RESULTS: In the 0.8% HA group, P. gingivalis CFUs/ml were significantly higher at baseline than at 24- (P<0.05), 48 (P<0.05) and 72 hours (P<0.05) intervals. In the 0.2% CHX group, P. gingivalis CFUs/ml were significantly higher at baseline than at 72 hours interval (P<0.05). In the CHX group, there was no difference in P. gingivalis CFUs/ml between baseline, 24- and 48-hours intervals. At 48- and 72-hours intervals, the P. gingivalis CFUs/ml were significantly higher in the 0.2% CHX group compared with the 0.8% HA group. CONCLUSION: In-vitro, 0.8% HA is more effective in reducing the P. gingivalis CFUs/ml compared with 0.2% CHX. Professional Medical Publications 2020 /pmc/articles/PMC6994868/ /pubmed/32063942 http://dx.doi.org/10.12669/pjms.36.2.1456 Text en Copyright: © Pakistan Journal of Medical Sciences http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Binshabaib, Munerah
Aabed, Kawther
Alotaibi, Fitoon
Alwaqid, Milaf
Alfraidy, Aljohara
Alharthi, Shatha
Antimicrobial efficacy of 0.8% Hyaluronic Acid and 0.2% Chlorhexidine against Porphyromonas gingivalis strains: An in-vitro study
title Antimicrobial efficacy of 0.8% Hyaluronic Acid and 0.2% Chlorhexidine against Porphyromonas gingivalis strains: An in-vitro study
title_full Antimicrobial efficacy of 0.8% Hyaluronic Acid and 0.2% Chlorhexidine against Porphyromonas gingivalis strains: An in-vitro study
title_fullStr Antimicrobial efficacy of 0.8% Hyaluronic Acid and 0.2% Chlorhexidine against Porphyromonas gingivalis strains: An in-vitro study
title_full_unstemmed Antimicrobial efficacy of 0.8% Hyaluronic Acid and 0.2% Chlorhexidine against Porphyromonas gingivalis strains: An in-vitro study
title_short Antimicrobial efficacy of 0.8% Hyaluronic Acid and 0.2% Chlorhexidine against Porphyromonas gingivalis strains: An in-vitro study
title_sort antimicrobial efficacy of 0.8% hyaluronic acid and 0.2% chlorhexidine against porphyromonas gingivalis strains: an in-vitro study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994868/
https://www.ncbi.nlm.nih.gov/pubmed/32063942
http://dx.doi.org/10.12669/pjms.36.2.1456
work_keys_str_mv AT binshabaibmunerah antimicrobialefficacyof08hyaluronicacidand02chlorhexidineagainstporphyromonasgingivalisstrainsaninvitrostudy
AT aabedkawther antimicrobialefficacyof08hyaluronicacidand02chlorhexidineagainstporphyromonasgingivalisstrainsaninvitrostudy
AT alotaibifitoon antimicrobialefficacyof08hyaluronicacidand02chlorhexidineagainstporphyromonasgingivalisstrainsaninvitrostudy
AT alwaqidmilaf antimicrobialefficacyof08hyaluronicacidand02chlorhexidineagainstporphyromonasgingivalisstrainsaninvitrostudy
AT alfraidyaljohara antimicrobialefficacyof08hyaluronicacidand02chlorhexidineagainstporphyromonasgingivalisstrainsaninvitrostudy
AT alharthishatha antimicrobialefficacyof08hyaluronicacidand02chlorhexidineagainstporphyromonasgingivalisstrainsaninvitrostudy